Webcast is Live at 4:00 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jul. 23, 2013--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its third
quarter 2013 conference call on Wednesday, July 31, at 4:00 p.m. CT
(5:00 p.m. ET). The Company will issue an earnings news release after
the market closes that afternoon.
Gary Maharaj, chief executive officer, and Andy LaFrence, vice president
of finance and chief financial officer, will recap the third quarter
2013 financial results and accomplishments. To access the webcast, go to
the investor relations portion of the Company’s website at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on
Wednesday, July 31, until 7:00 p.m. CT on Wednesday, August 7, and can
be accessed by dialing 800-406-7325 and entering conference call ID
passcode 4632073. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance
patients’ well-being by providing the world’s foremost, innovative
surface modification technologies and in vitro diagnostic
chemical components. SurModics partners with the world’s leading and
emerging medical device, diagnostic and life science companies to
develop and commercialize innovative products designed to improve
patient diagnosis and treatment. Core offerings include surface
modification coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro
diagnostic test kits and microarrays. SurModics is headquartered in Eden
Prairie, Minnesota. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
